TransFind—predicting transcriptional regulators for gene sets by Kiełbasa, Szymon M. et al.
TransFind—predicting transcriptional regulators
for gene sets
Szymon M. Kiełbasa
1,*, Holger Klein
1, Helge G. Roider
1, Martin Vingron
1 and
Nils Blu ¨thgen
2,*
1Max Planck Institute for Molecular Genetics, Ihnestraße 73, D-14195 Berlin and
2Institute of Pathology and
Institute of Theoretical Biology, Charite ´ Universita ¨tsmedizin Berlin, Charite ´platz 1, D-10115 Berlin, Germany
Received January 31, 2010; Revised April 30, 2010; Accepted May 7, 2010
ABSTRACT
The analysis of putative transcription factor binding
sites in promoter regions of coregulated genes
allows to infer the transcription factors that
underlie observed changes in gene expression.
While such analyses constitute a central component
of the in-silico characterization of transcriptional
regulatory networks, there is still a lack of
simple-to-use web servers able to combine
state-of-the-art prediction methods with phylogen-
etic analysis and appropriate multiple testing cor-
rected statistics, which returns the results within
a short time. Having these aims in mind we de-
veloped TransFind, which is freely available at
http://transfind.sys-bio.net/.
INTRODUCTION
Searching for functional transcription factor binding sites
in promoter regions has been a problem addressed for
decades. Still, due to the short length of sequence motifs
recognized by most vertebrate transcription factors and
the excessively large non-coding DNA regions in these
genomes, the annotation of binding sites in individual pro-
moters is dominated by false predictions (1). A possible
way to improve the speciﬁcity of the prediction for
individual binding sites comes from considering the
evolutionary conservation of a binding site between
diﬀerent species (2). The utility of such phylogenetic
analysis has been demonstrated in ﬁnding distal
enhancer regions (3). However, when concerned with
proximal promoters, the advantage of using conserva-
tion is still debated. It has been shown that the conserva-
tion of individual binding sites diﬀers strongly between
diﬀerent transcription factors (4). It could be
argued that evolutionary pressure does not necessarily
lead to conservation of an individual binding site, but
rather to conservation of a general ability of the tran-
scription factor to bind somewhere in the promoter and
regulate the gene accordingly. Therefore, a possible way
to alleviate this problem stems from approaches that
predict the aﬃnity of a transcription factor to entire
promoter regions rather than to individual binding
sites within them. Such aﬃnity-based methods avoid the
artiﬁcial separation between transcription factor binding
sites and non-binding sites and were shown to emulate
the in vivo binding behaviour more quantitatively than
hit-based approaches (5–8). By ranking all promoters of
a genome based on the predicted aﬃnities, one can extract
the likely candidate target genes of a particular transcrip-
tion factor.
Statistical meta-analyses such as testing for enrichment
of predicted sites or target genes in a set of coregulated
genes, or in a set of genes with shared function, have been
proven most useful to discover the transcription factors
underlying the observed expression pattern (9,10). Such
approaches draw upon the idea that a particular transcrip-
tion factor likely regulates several genes at once. The cor-
responding predicted target genes should thus be enriched
within the set of co-regulated genes.
To solve the problem of identifying the transcription
factors regulating a given set of genes, a number of
methods have been proposed that use either the annota-
tion of discrete binding sites or continuous binding
aﬃnities (11–14). To determine the statistical signiﬁcance
of the results, most methods rely on computationally ex-
pensive resampling procedures or utilize discrete binding
sites instead of aﬃnity scores to predict the target genes of
each individual transcription factor. In contrast, we
present a method available through an easy-to-use web
interface, which combines aﬃnity measures (5) and
support for phylogenetic analysis with rigorous statistics
(9), and that returns the results within short time.
Moreover, TransFind also features visualization of the
GC- and CpG content of promoter sequences as well as
the binding sites, which allows inspection and interpret-
ation of the nucleotide composition of the input sequence
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TransFind SERVER
The TransFind service has been designed to conveniently
solve a well-deﬁned biological question: which transcrip-
tion factor (TF) is a likely regulator of a given set of genes
(in the following termed the positive set)? Such sets would
for example consist of genes found to be up-regulated in a
microarray experiment after a perturbation. In order to
answer that question, we have set up an analysis pipeline
and web server (illustrated in Figure 1).
When starting the analysis, the user is requested to
provide a list of genes for the positive set. Lists are
accepted in the form of any of the popular identiﬁers
that are available as cross-references in Ensembl, such as
Entrez Gene IDs or names, Ensembl identiﬁers or corres-
ponding Aﬀymetrix probe IDs. After submission,
TransFind tests whether the list contains a signiﬁcantly
enriched number of putative target genes for any of the
supported transcription factors. As targets, we deﬁne
those genes of which the promoters display top-ranking
aﬃnities to the respective transcription factor.
The enrichment is measured with respect to another set
of genes (the negative set) that by default contains all
other genes of the organism. Often, it may be more ap-
propriate to deﬁne only a subset of all genes to be the
negative set. Such a list can be provided by the user. A
typical user-deﬁned negative set would consist of all genes
that were found to be expressed in the microarray study,
but do not show a change in expression between the con-
ditions. Since genes can only be in either the positive set or
in the negative set, TransFind automatically excludes
genes present in the positive set from the negative set.
We use Fisher’s exact test (Figure 2) to quantify enrich-
ment of putative high-aﬃnity targets of a transcription
factor in the positive set. Since we test for the enrichment
of a multitude of transcription factor matrices, correcting
for multiple testing is an issue. We have previously estab-
lished an analytical approach (9) to determine the false
discovery rate (FDR).
Once corrected for multiple testing, TransFind reports
the results as a table of transcription factor matrices
ranked by the enrichment of their predicted targets in
the positive set. By default, only the signiﬁcant results
are shown. We deﬁne any transcription factor matrix as
signiﬁcant if the corresponding FDR is <0.05, which
limits the fraction of false predictions to 5%.
Additionally, a link is provided to a table listing the
detailed results for all analysed transcription factor
matrices.
An example of the output which includes the supporting
statistical details are is given in Table 1. For each tran-
scription factor matrix, the server reports how many of the
genes from the positive set have a promoter with strong
predicted aﬃnity to the factor. This can be compared to
the number of predicted promoters with high aﬃnity to
the factor in the negative set. The results of the statistical
test are provided in further columns, including the corres-
ponding P-value of the Fisher’s exact test, FDR and
expected numbers of false positives (FPs). TransFind
also displays the logo of the sequence motif that is
recognized by the transcription factor (15). It is possible
to obtain the results in a simple text format or in the XML
format containing additional details on the mapping of
the input gene identiﬁers.
To facilitate rapid calculation, we utilize arrays contain-
ing precalculated aﬃnity scores to all promoter regions.
Additionally, we provide precalculated scores for phylo-
genetically conserved regions. These scores were
calculated for all genes that have orthologues in another
selected vertebrate species, by taking either the average or
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Figure 2. TransFind identiﬁes transcription factors with signiﬁcantly
enriched numbers of predicted targets in the regulated gene set with
respect to an unregulated set. (A) The putative targets of factor 1 dis-
tribute randomly among the regulated genes (positive set) and
non-regulated genes (negative set). (B) In contrast, the top targets of
factor 2 are strongly enriched in the regulated genes.
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Figure 1. General overview of the algorithm.
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allows detecting promoters where the individual binding
sites might not be conserved, but for which the transcrip-
tion factor still binds with high aﬃnity in both organisms.
The strongest enrichment for functional transcription
factor binding sites has been previously found to lie
within the ﬁrst few 100 base pairs upstream of the tran-
scription start site (16). Therefore, our default promoter
set contains promoter sequences ranging from 300nt
upstream of the gene start to 100nt downstream of the
gene start annotated in Ensembl. In addition, users may
select another promoter set that consists of sequences
spanning from 800nt upstream to 200nt downstream of
the gene start.
We provide three diﬀerent sets of transcription factor
matrices. First, the user may select a complete set of ver-
tebrate transcription factor matrices that are contained in
the Transfac database (17). As this complete set of
matrices is highly redundant, the results are often diﬃcult
to interpret (18). Therefore, we created a reduced set of
matrices containing only a single, the most informative
matrix for each vertebrate Transfac transcription factor.
The third set of matrices has been downloaded from the
rapidly developing and free transcription factor binding
proﬁle database Jaspar (19).
PERFORMANCE EVALUATION
Based on published experimental data, we collected six
sets of target genes for the following transcription
factors: c-myc (20), E2F (21), NFkB (22), Hif1a (23),
Hnf4 (http://www.sladeklab.ucr.edu/hnf43.pdf) and Ets1
(24). Table 1 illustrates the output from TransFind
obtained for the set of c-myc-regulated genes. The enrich-
ment has been computed for the overlap between the 51
input genes and the top 500 targets for each TF as pre-
dicted from the aﬃnities for short promoters of length
400bp. For this data set, TransFind predicts the
myc-related transcription factor N-Myc as strongly
associated.
Also, for each of the literature test sets of Hif1a, Hnf4
and E2F targets. TransFind correctly identiﬁes the corres-
ponding TF matrices as most signiﬁcantly enriched. In
case of E2F and the complete set of Transfac matrices,
one obtains all 21 variants of the E2F matrix as signiﬁ-
cantly associated. In contrast, for the reduced set of
matrices, the algorithm returns only three of the most in-
formative matrices of the E2F transcription factors. The
set of E2F targets also illustrates that TransFind warns the
user when an unusual CpG composition is found in the
promoters of the provided genes. The histograms display-
ing bias of the CpG- or GC composition might be then
inspected (see below). Similarly, for the NFkB target set
and the reduced set of matrices, TransFind reports four
similar NFkB motifs as well as the related factors c-REL
and HMG as likely regulators of the set. In comparison,
TransFind returns 21 redundant NFkB matrices when
utilizing the full matrix set.
Finally, TransFind reports no signiﬁcantly associated
TF for the set of Ets1 targets when using the
standard FDR cut-oﬀ of 0.05, indicating that none of
the transcription factor matrices has enriched aﬃnity for
the promoters of the targets of Ets1. However, when the
signiﬁcance cut-oﬀ is relaxed, the correct TF motif is re-
covered at position six after several matrices correspond-
ing to the transcription factor AP1 as well as a matrix
from BACH1.
We veriﬁed how many genes are suﬃcient to identify an
associated transcription factor. Hence, we generated
random subsets of the literature-derived E2F, NFkB and
c-myc gene sets of diﬀerent sizes and ran TransFind on
them. We then deﬁned sensitivity as the fraction of runs
for which the correct transcription factor was recovered.
The results are shown in Figure 3. It turns out that
minimum positive set size depends on the transcription
factor, however, for the set of E2F targets even small
subsets of 10 genes are often suﬃcient.
In summary, TransFind provides predictions in agree-
ment with biological knowledge in ﬁve out of six available
experimental data sets. These predictions are robust with
respect to changes of the parameters. The analyses can be
easily repeated with the help of example buttons loading
the experimental data sets.
In order to estimate TransFind performance, we
prepared gene sets annotated with the same Gene
Ontology term. By limiting the sets to genes annotated
with terms close to the root of the ontology (not more
than 2 steps away from biological process, molecular
function or cellular location) and taking only sets with
more than 10 genes, we constructed 397 gene sets that
we systematically analyse. We expect that many of these
sets are not correlated in their expression. However, some
of these sets will be coregulated and therefore consist of
genes that share transcription factors that regulate them.
Thus, these sets can be used to systematically analyse the
performance of TransFind with diﬀerent parameter
settings, but it has to be kept in mind that the sensitivity
will be under-estimated. We found that (e.g. using the top
200 genes as targets and the default promoter set of length
Table 1. An example of a TransFind result showing all signiﬁcant transcription factor matrices predicted to regulate a known set of 51 c-myc
targets
Rank TF matrix P-value FDR FP Hits in positive set ES (%) Hits in negative set ES (%)
1 V$NMYC_01 / N-Myc 0.000001 0.000001 0.000001 11 (22.45) 489 (0.98)
The top 500 predicted targets of each transcription factor were analysed. The set of matrices was limited to the most informative per Transfac factor.
Following the matrix and factor names, the P-value, FDR and expected number of FP are reported. Furthermore, the number of high-aﬃnity
matches for the factor in the positive set and in the negative set are shown, together with their relative abundance.
Nucleic AcidsResearch, 2010, Vol.38, WebServer issue W277400nt) 23% of the gene sets were predicted to be regulated
by at least one transcription factor. One hundred and
twenty-one out of the non-redundant set of 217 transcrip-
tion factor matrices were predicted to regulate at least one
set, suggesting that it is not a small group of matrices that
dominates the analysis.
Next, we investigated whether phylogenetic informa-
tion improves the prediction performance. When using
average aﬃnity for human and mouse, we observe a
mild reduction in the number of predictions. In contrast,
when using minimal aﬃnity, more regulating transcription
factors are predicted. We summarize these results in
Figure 4.
The fraction of false predictions was estimated using
diﬀerent randomization scenarios. First, we shuﬄed pos-
itions within each transcription factor matrix. This
method gave the highest estimations of the fraction of
falsely predicted factors. However, we interpret this
result as an overestimation, since a shuﬄed matrix is
often by chance very similar to the original matrix (espe-
cially for repetitive or skewed matrices). Next, we ran
TransFind on promoter sets with nucleotide sequences
shuﬄed within each promoter. The resulting fraction of
false predictions was <5%. If conservation was taken into
account by using average aﬃnities between human and
mouse orthologues, the fraction of false predictions was
even smaller. In contrast, when using minimal aﬃnities,
the number of false predictions increased as did the
number of predictions. Finally, we also sampled random
gene sets with the same size distribution as for the refer-
ence 397 gene sets. For only about 2% of these random
gene sets was any signiﬁcant factor found, independent of
whether conservation was used or not. Overall, the results
suggest that for about 5–8% of submitted gene set sets,
false predictions are returned. Choosing minimal aﬃnity,
the results show more predictions but at the cost of
increased number of false predictions. In contrast, by
using average aﬃnity the amount of false predictions
can be reduced.
Based on the results for shuﬄed promoters, one could
deduce that false predictions occur mainly because of
biased nucleotide composition of the promoter sequences.
In the analysis of the 397 Gene Ontology groups, we
identiﬁed 17 groups (5%) with promoters displaying
either unusually high or low CpG- or GC content.
Therefore, TransFind additionally provides a test for
gene sets with biased promoters and displays a warning
when such a signiﬁcant enrichment occurs. The user
should then carefully consider whether the transcription
factors are found only due to the overall promoter com-
position, and if other modes of regulation such as epigen-
etic regulation should be investigated.
To assess whether the short core promoter regions
are suﬃcient to predict the regulating factors, we
repeated the analysis on a set of promoters of length
1000nt, which showed no better performance. This obser-
vation is also supported by the comparison of the short
core promoter regions directly upstream of them (from
700nt upstream to 300nt upstream of the gene start
sites). Predictions for these shifted regions were hardly
better than the predictions for the shuﬄed promoter
sequences.
A
B
Figure 4. Performance of TransFind. We deﬁned 397 sets of genes
which were annotated with top Gene Ontology terms and
searched for enriched putative transcription factor targets using diﬀer-
ent parameters. Results for original data (dark grey) are compared
to results for shuﬄed matrices or promoter sequences (medium
grey) or to random gene sets of the same size distribution
(light grey). Panel A shows the fraction of GO sets with at least one
signiﬁcant factor and panel B shows the average number of discovered
factors in a GO set.
Figure 3. Sensitivity of TransFind for diﬀerent sizes of the positive
gene set. We used TransFind on random subgroups of literature-
derived E2F, c-myc and NFkB target genes in order to determine
minimum number of genes suﬃcient for correct identiﬁcation of the
regulating transcription factor. We deﬁned sensitivity as the fraction
of randomly selected subgroups, which resulted in a signiﬁcant predic-
tion of the respective transcription factor. We used default TransFind
settings (500 top aﬃnities, subset of Transfac matrices with highest
information content).
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taking the short core promoters (300nt upstream to
100nt downstream of gene start) together with minimum
aﬃnity in mouse and human provides the best sensitivity
without many false predictions.
IMPLEMENTATION DETAILS
Extraction of promoter sequences
The Ensembl database (25) in its current version 57 is used
as the source of genomic sequences and corresponding
gene annotations. We extracted two sets of putative pro-
moters: short—covering the range of 300nt upstream to
100nt downstream and long—from 800nt upstream to
200nt downstream of the most upstream transcription
start site.
Prediction of binding aﬃnities
We use a previously published approach (5) to calculate
binding aﬃnities of a transcription factor to a gene
promoter. Since this calculation is time-consuming, we
precalculated arrays of the aﬃnities for all promoters
and all transcription factors. We used either all vertebrate
transcription factor matrices available in Transfac (17)
version 2009.4 or the non-redundant vertebrate matrices
from Jaspar core (19). Additionally, since Transfac is
highly redundant, we used a subset of matrices, where
for each transcription factor we select the matrix
with the highest information content. Apart from the
calculation of the diﬀerent transcription factor binding
aﬃnities, we determine the GC- and CpG content (26)
of each promoter sequence and subsequently use these
values along with the aﬃnities in the statistical test.
Phylogenetic analysis
TransFind provides an option to consider only phylogen-
etically conserved regulation. In this mode, aﬃnity of a
factor to a gene is combined with aﬃnity of the same
factor to the gene orthologue in a selected organism.
Either minimum or average of the two aﬃnities is
computed. In the minimum mode, genes with high
aﬃnities in both organisms are top ranked.
Identiﬁer mapping
In the ﬁrst step of analysis, TransFind maps provided
input gene names to the genes present in the aﬃnity
arrays. The mapping tables are constructed based on the
cross-reference annotations available for each gene in
Ensembl. If an input identiﬁer is mapped to several
genes, all of them are included in further analysis.
Multiple occurrences of the same gene are uniﬁed auto-
matically. To guarantee that there is no overlap between
positive and negative sets, all genes common to both sets
are excluded from the negative set of genes. Thus, users
can simply paste their gene sets without any prior conver-
sion directly into to the input form and immediately start
TransFind. If no negative set is provided, all genes of the
genome that are not in the positive set are taken.
Statistical analysis
For each transcription factor we identify a chosen number
of top-ranking genes based on precalculated aﬃnities.
Subsequently, using a multiple testing corrected Fisher’s
exact test we check whether there exists a transcription
factor with top-ranked genes enriched among the
submitted positive set of genes when compared to the
negative set of genes (27).
Web server
The results are presented in a form of a ranked table, with
links to pages providing more information about position-
al frequency matrices and corresponding transcription
factors. We also display sequence logos to visualize the
positional frequency matrices and provide histograms of
the GC- and CpG content of the positive and negative
sequence sets. Internally, all computed results are kept in
XML format. The functionality of the web server is
embedded into a content management system (Joomla),
which allows to eﬃciently manage multiple sessions and
to rapidly change the description and help pages to update
the web site and incorporate user suggestions.
CONCLUSIONS
We have implemented an easy-to-use web server that
allows to predict transcription factors regulating a set of
genes using state-of-the-art methods. The method has
been successfully evaluated on various data sets. The
web site is free and open to all users at http://transﬁnd
.sys-bio.net/ and there is no login requirement.
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